uridine diphosphate glucose has been researched along with colforsin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dickenson, JM; Scrivens, M | 1 |
Barrett, MO; Burianek, LE; Carter, RL; Das, A; Fricks, IP; Harden, TK; Jacobson, KA; Ko, H; Lazarowski, ER; Zhou, Y | 1 |
Abbas, ZSB; Dovlatova, N; Dunn, WR; Fox, SC; Heptinstall, S; Latif, ML; Ralevic, V | 1 |
3 other study(ies) available for uridine diphosphate glucose and colforsin
Article | Year |
---|---|
Functional expression of the P2Y14 receptor in human neutrophils.
Topics: Cells, Cultured; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pancreatic Elastase; Phosphorylation; Receptors, Purinergic P2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Uridine Diphosphate Galactose; Uridine Diphosphate Glucose; Uridine Diphosphate Glucuronic Acid; Uridine Diphosphate Sugars | 2006 |
Quantification of Gi-mediated inhibition of adenylyl cyclase activity reveals that UDP is a potent agonist of the human P2Y14 receptor.
Topics: 1-Methyl-3-isobutylxanthine; Adenylyl Cyclase Inhibitors; Animals; Cell Line; CHO Cells; Colforsin; Cricetinae; Cricetulus; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; GTP-Binding Proteins; HL-60 Cells; Humans; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Signal Transduction; Uridine Diphosphate; Uridine Diphosphate Glucose | 2009 |
UDP-sugars activate P2Y
Topics: Adult; Animals; Colforsin; Coronary Vessels; Female; Humans; Isothiocyanates; Male; Receptors, Purinergic P2; Signal Transduction; Swine; Thiourea; Uridine Diphosphate Glucose; Uridine Diphosphate Sugars; Vasoconstriction; Vasoconstrictor Agents | 2018 |